Documentation of acute episodes of TTP following infection [3], inflammation [4], and pharmacologic treatment with interferon-α, a type I interferon (IFN) [5], suggests that inflammation is a possible trigger of acute episodes in this disorder. Here, IFNA1 is linked to thrombotic thrombocytopenic purpura.